Cannon Global Investment Management »

BioCryst Pharmaceuticals shares owned by Cannon Global Investment Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Cannon Global Investment Management from 13F filings

Historical chart of Cannon Global Investment Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Cannon Global Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $253k 27k 9.52

More positions owned by Cannon Global Investment Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Norfolk Southern (NSC)
Terns Pharmaceuticals (TERN)
Sun Communities (SUI)
Madrigal Pharmaceuticals (MDGL)
Cheniere Energy Com New (LNG)
Qiagen Nv Ord Shares (QGEN)
Zoom Communications Cl A (ZM)
Cantor Equity Partners I Shs Cl A (CEPO)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Marvell Technology (MRVL)
Cantor Equity Partners Ii In Cl A Ord Shs (CEPT)
Renatus Tactical Acquis Shs Cl A (RTAC)
Ss&c Technologies Holding (SSNC)

View all positions for Cannon Global Investment Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
RA Capital Management
Deerfield Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation

View all funds holding BioCryst Pharmaceuticals